Ignite Creation Date:
2024-05-06 @ 12:46 AM
Last Modification Date:
2024-10-26 @ 10:54 AM
Study NCT ID:
NCT01654185
Status:
COMPLETED
Last Update Posted:
2017-03-14
First Post:
2012-07-27
Brief Title:
Dimethyldiguanide Combined With Aromatase Inhibitor AI in Metastatic Breast Cancer
Sponsor:
Xichun Hu
Organization:
Fudan University
Study Overview
Official Title:
Phase II Study of Dimethyldiguanide Combined With AI Compared to AI in Postmenopausal HR Metastatic Breast Cancer
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The addition of dimethyldiguanide might increase the efficacy of AI treatment in metastatic breast cancer
Detailed Description:
The addition of dimethyldiguanide might increase the efficacy of AI in patients with metastatic breast cancer after the failure of the first line endocrine therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None